We maintain BUY. Symphony reported a weak but in-line performance in a non-seasonal quarter. Domestic revenues contracted by 33% (+27% in 3QFY18; -21% in 2QFY19) vs. exp. of -25% owing to high channel inventory. Standalone EBITDA/PAT grew by -45/-36% vs. expectations of -30/-26%.